| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |